SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits

By sjmartinez • October 11, 2022

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003. PMID: 36216488.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with preserved ejection fraction, Heart failure with reduced ejection fraction, Initiation and sequencing, Publications

When Is Enough Enough? Additional Evidence of the Power of Zero

Budoff MJ. When Is Enough Enough? Additional Evidence of the Power of Zero. Circ Cardiovasc Imaging. 2024 Dec 20:e017714. doi: 10.1161/CIRCIMAGING.124.017714. Epub ahead of print.[...]

“Anti-inflammatory Therapies in Atherosclerosis – Where are we going?”

Punnanithinont N, Kambalapalli S, Iskander B, Ichikawa K, Krishnan S, Lakshmanan S, Roy SK, Budoff M. "Anti-inflammatory Therapies in Atherosclerosis - Where are we going?".[...]

First comparison between artificial intelligence-guided coronary computed tomography angiography versus single-photon emission computed tomography testing for ischemia in clinical practice

Cho GW, Sayed S, D'Costa Z, Karlsberg DW, Karlsberg RP. First comparison between artificial intelligence-guided coronary computed tomography angiography versus single-photon emission computed tomography testing[...]